Patient & Visitor InformationContact Us
  • Hematology Protocols

  • Lymphoma

    1. BrUOG NHL-227: Ofatumumab and Bortezomib in Patients with Low-Grade Non-Hodgkin Lymphoma that Relapse after Rituximab
      PI: Jorge Castillo, MD
      Sites: Rhode Island Hospital, The Miriam Hospital

    2. FolBrite: A Multicenter, Open Label, Phase II Study of Bendamustine and Rituximab followed by 90-yttrium (Y) Ibritumomab Tiuxetan for Untreated Follicular Lymphoma  (D1015)
      PI: Eric Winer, MD
      Sites: Rhode Island Hospital, The Miriam Hospital